Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients

Management of KPC-producing Klebsiella pneumoniae infections

(2018) M. Bassetti et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , and Acinetobacter spp.

(2018) E. Matuschek et al.   CLINICAL MICROBIOLOGY AND INFECTION

Risk Factors, Clinical Presentation, and Outcome of Acinetobacter baumannii Bacteremia

(2017) Tala Ballouz et al.   Frontiers in Cellular and Infection Microbiology

Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii

(2017) Yong Kyun Kim et al.   Journal of Thoracic Disease

Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria

(2017) Stefano Busani et al.   JOURNAL OF INTENSIVE CARE MEDICINE

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

(2017) Thomas F. Durand-Réville et al.   Nature Microbiology

Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia

(2016) M.P. Freire et al.   CLINICAL MICROBIOLOGY AND INFECTION

Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae

(2016) M. Falcone et al.   CLINICAL MICROBIOLOGY AND INFECTION

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization

(2016) Tai-Chin Hsieh et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae

(2016) Joshua T. Thaden et al.   Virulence

Interactions of Klebsiella pneumoniae with the Innate Immune System Vary in Relation to Clone and Resistance Phenotype

(2015) Iliana-Maria Pantelidou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit

(2015) Giancarlo Ceccarelli et al.   BMC INFECTIOUS DISEASES

Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study

(2015) D.R. Giacobbe et al.   CLINICAL MICROBIOLOGY AND INFECTION

Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia

(2015) Aristine Cheng et al.   CRITICAL CARE MEDICINE

In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis

(2015) Wentao Ni et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comment on: Infections caused by KPC-producingKlebsiella pneumoniae: differences in therapy and mortality in a multicentre study

(2015) C. Tascini et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial

(2015) Claudine Angela Blum et al.   LANCET

Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems

(2013) Oren Zusman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae

(2013) Giancarlo Ceccarelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence

(2013) Matthew E. Falagas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria

(2013) Nicola Petrosillo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

(2013) José Garnacho-Montero et al.   CHEMOTHERAPY

Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria

(2013) Mario Tumbarello et al.   CHEST

Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

(2013) Emanuele Durante-Mangoni et al.   CLINICAL INFECTIOUS DISEASES

KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality

(2013) Matthaios Papadimitriou-Olivgeris et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

(2012) A. Capone et al.   CLINICAL MICROBIOLOGY AND INFECTION

Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study

(2012) Mitchell M Levy et al.   LANCET INFECTIOUS DISEASES

Guidelines for the prevention of intravascular catheter-related infections

(2011) Naomi P. O'Grady et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment

(2011) O. Zarkotou et al.   CLINICAL MICROBIOLOGY AND INFECTION

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

(2011) G.L. Daikos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007

(2011) Tara Lagu et al.   CRITICAL CARE MEDICINE

Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: Risk factors and impact on mortality

(2011) Melda Turkoglu et al.   JOURNAL OF CRITICAL CARE

Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock

(2011) John D. Dickinson et al.   Current Infectious Disease Reports

Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination

(2010) F. Perez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotic Usage and Resistance

(2009) Steven M. Opal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antimicrobial resistance in Europe and its potential impact on empirical therapy

(2008) G.M. Rossolini et al.   CLINICAL MICROBIOLOGY AND INFECTION